DAPK2 and central nervous system cancer: In addition, altered DAPK2 gene expression serves as a potential biomarker for the diagnosis of a variety of diseases such as Parkinson’s disease, colorectal cancer, and gliomas (Bao et al., 2024; Li et al., 2024; Xu et al., 2020).